2013 annual financial data
Aurinia Pharmaceuticals 2013 Operating margin
Aurinia Pharmaceuticals 2013 operating margin with verified reported values.
Direct answer
Operating margin was -580.4%.
Operating income was -5,505,414.31 USD and net income was -2,546,089.77 USD.
Operating cash flow was -4,523,042.54 USD.
Get free Aurinia Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 948,561 USD
- Operating income
- -5,505,414.31 USD
- Net income
- -2,546,089.77 USD
- Operating cash flow
- -4,523,042.54 USD